Literature DB >> 7145771

A developmental view of endometrial hyperplasia and carcinoma based on experimental research.

L E Gerschenson, R H Fennell.   

Abstract

On the basis of experimental research, using rabbit uterine epithelium as a model, it is postulated that human endometrial hyperplasia or carcinoma may be due to derangement of intrinsic growth mechanisms such as cell proliferation, migration, loss and differentiation. Ovarian hormones, estrogen inhibitor or amplifying factors, prostaglandins, stroma-epithelial interactions, proteolytic activity and hormone receptors, all regulate the described intrinsic growth mechanisms, and their excess or lack could result in altered growth patterns. It is also proposed that different types of endometrial carcinoma could result from neoplastic transformation of cells at different stages of differentiation. Since cells at those stages could respond to various hormones in different ways, it would seem of therapeutic value to know the cell of origin in each type of endometrial carcinoma.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7145771     DOI: 10.1016/S0344-0338(82)80071-X

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  3 in total

1.  Evidence for soluble factors regulating cell death and cell proliferation in primary cultures of rabbit endometrial cells grown on collagen.

Authors:  M P Lynch; S Nawaz; L E Gerschenson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

2.  Cystic Fibrosis Transmembrane Conductance Regulator Potentiation as a Therapeutic Strategy for Pulmonary Edema: A Proof-of-Concept Study in Pigs.

Authors:  Xiaopeng Li; Luis G Vargas Buonfiglio; Ryan J Adam; David A Stoltz; Joseph Zabner; Alejandro P Comellas
Journal:  Crit Care Med       Date:  2017-12       Impact factor: 7.598

3.  Hormonal regulation of cell death in rabbit uterine epithelium.

Authors:  S Nawaz; M P Lynch; P Galand; L E Gerschenson
Journal:  Am J Pathol       Date:  1987-04       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.